150 related articles for article (PubMed ID: 15365035)
1. Antimicrobial susceptibilities of invasive pediatric Abiotrophia and Granulicatella isolates.
Zheng X; Freeman AF; Villafranca J; Shortridge D; Beyer J; Kabat W; Dembkowski K; Shulman ST
J Clin Microbiol; 2004 Sep; 42(9):4323-6. PubMed ID: 15365035
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Abiotrophia adiacens and Abiotrophia defectiva.
Tuohy MJ; Procop GW; Washington JA
Diagn Microbiol Infect Dis; 2000 Nov; 38(3):189-91. PubMed ID: 11109021
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Susceptibilities of Abiotrophia defectiva, Granulicatella adiacens, and Granulicatella elegans.
Alberti MO; Hindler JA; Humphries RM
Antimicrob Agents Chemother; 2015 Dec; 60(3):1411-20. PubMed ID: 26666926
[TBL] [Abstract][Full Text] [Related]
4. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
Muhtarova AA; Gergova RT; Mitov IG
J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
[TBL] [Abstract][Full Text] [Related]
5. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.
Green M; Martin JM; Barbadora KA; Beall B; Wald ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):473-6. PubMed ID: 14742197
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities and occurrence of resistance genes in bovine Helcococcus ovis isolates.
Bilk S; Nordhoff M; Schulze C; Wieler LH; Kutzer P
Vet Microbiol; 2011 May; 149(3-4):488-91. PubMed ID: 21131144
[TBL] [Abstract][Full Text] [Related]
7. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
Bae S; Lee K
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results.
Desjardins M; Delgaty KL; Ramotar K; Seetaram C; Toye B
J Clin Microbiol; 2004 Dec; 42(12):5620-3. PubMed ID: 15583291
[TBL] [Abstract][Full Text] [Related]
9. Comparison of MALDI-TOF MS and VITEK 2 system for laboratory diagnosis of Granulicatella and Abiotrophia species causing invasive infections.
Ratcliffe P; Fang H; Thidholm E; Boräng S; Westling K; Özenci V
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):216-9. PubMed ID: 24034902
[TBL] [Abstract][Full Text] [Related]
10. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
[TBL] [Abstract][Full Text] [Related]
11. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
Ergin A; Ercis S; Hasçelik G
J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia.
Reinert RR; Filimonova OY; Al-Lahham A; Grudinina SA; Ilina EN; Weigel LM; Sidorenko SV
Antimicrob Agents Chemother; 2008 Jun; 52(6):2260-2. PubMed ID: 18378707
[TBL] [Abstract][Full Text] [Related]
13. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
Morosini MI; Cantón R; Loza E; Negri MC; Galán JC; Almaraz F; Baquero F
Antimicrob Agents Chemother; 2001 Sep; 45(9):2427-31. PubMed ID: 11502509
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates.
Figueira-Coelho J; Ramirez M; Salgado MJ; Melo-Cristino J
Microb Drug Resist; 2004; 10(1):31-6. PubMed ID: 15140391
[TBL] [Abstract][Full Text] [Related]
16. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
17. Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital.
Acikgoz ZC; Almayanlar E; Gamberzade S; Gocer S
Antimicrob Agents Chemother; 2004 Apr; 48(4):1410-2. PubMed ID: 15047555
[TBL] [Abstract][Full Text] [Related]
18. Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.
Mushtaq A; Greenwood-Quaintance KE; Cole NC; Kohner PC; Ihde SM; Strand GJ; Harper LW; Virk A; Patel R
Antimicrob Agents Chemother; 2016 Aug; 60(8):5036-9. PubMed ID: 27216060
[TBL] [Abstract][Full Text] [Related]
19. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
Wierzbowski AK; Boyd D; Mulvey M; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2005 Nov; 49(11):4635-40. PubMed ID: 16251306
[TBL] [Abstract][Full Text] [Related]
20. Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Murray CK; Walter EA; Crawford S; McElmeel ML; Jorgensen JH
Clin Infect Dis; 2001 May; 32(10):E140-2. PubMed ID: 11317266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
